CRISPR Therapeutics

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

Year Established: 2013 Stock Ticker: CRSP Exchange: NASDAQ

Locations